|
GB2434312B
(en)
|
2006-01-18 |
2011-06-29 |
Gw Pharma Ltd |
Cannabinoid-containing plant extracts as neuroprotective agents
|
|
GB2450753B
(en)
*
|
2007-07-06 |
2012-07-18 |
Gw Pharma Ltd |
New Pharmaceutical formulation
|
|
GB2451254A
(en)
*
|
2007-07-24 |
2009-01-28 |
Gw Pharma Ltd |
Cannabidiol for use in the treatment of neurodegenerative conditions
|
|
US20110257256A1
(en)
*
|
2008-07-31 |
2011-10-20 |
Bionoria Research Gmbh |
Cannabinoids for use in treating or preventing cognitive impairment and dementia
|
|
GB2471523A
(en)
|
2009-07-03 |
2011-01-05 |
Gw Pharma Ltd |
Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy
|
|
GB2478595B
(en)
*
|
2010-03-12 |
2018-04-04 |
Gw Pharma Ltd |
Phytocannabinoids in the treatment of glioma
|
|
TWI583374B
(zh)
|
2010-03-30 |
2017-05-21 |
Ｇｗ伐瑪有限公司 |
使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
|
|
GB2487183B
(en)
*
|
2011-01-04 |
2018-10-03 |
Otsuka Pharma Co Ltd |
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
|
|
GB2479153B
(en)
*
|
2010-03-30 |
2014-03-19 |
Gw Pharma Ltd |
The phytocannabinoid cannabidivarin (CBDV) for use in the treatment of epilepsy
|
|
US8445034B1
(en)
|
2010-11-02 |
2013-05-21 |
Albert L Coles, Jr. |
Systems and methods for producing organic cannabis tincture
|
|
GB2487712B
(en)
|
2011-01-04 |
2015-10-28 |
Otsuka Pharma Co Ltd |
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
|
|
GB201111261D0
(en)
|
2011-07-01 |
2011-08-17 |
Gw Pharma Ltd |
Cannabinoids for use in the treatment of neuro-degenerative diseases or disorders
|
|
GB2495118B
(en)
|
2011-09-29 |
2016-05-18 |
Otsuka Pharma Co Ltd |
A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
|
|
GB2504263B
(en)
|
2012-06-08 |
2015-09-16 |
Gw Pharma Ltd |
Synergistic therapies for neuroprotection
|
|
US20150313868A1
(en)
|
2012-12-18 |
2015-11-05 |
Kotzker Consulting Llc |
Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
|
|
IL240830B
(en)
|
2013-02-28 |
2022-08-01 |
Teewinot Tech Limited |
Processes for chemical engineering and the device for the synthesis of compounds
|
|
US10792318B2
(en)
|
2013-03-14 |
2020-10-06 |
Sc Laboratories, Inc. |
Bioactive concentrates and uses thereof
|
|
US10774288B2
(en)
|
2013-09-18 |
2020-09-15 |
The Werc Shop, LLC |
Terpene-based compositions, processes, methodologies for creation and products thereby
|
|
US10821240B2
(en)
|
2014-02-11 |
2020-11-03 |
Vapor Cartridge Technology Llc |
Methods and drug delivery devices using cannabis
|
|
US9220294B2
(en)
|
2014-02-11 |
2015-12-29 |
Timothy McCullough |
Methods and devices using cannabis vapors
|
|
US9380813B2
(en)
|
2014-02-11 |
2016-07-05 |
Timothy McCullough |
Drug delivery system and method
|
|
GB2530001B
(en)
|
2014-06-17 |
2019-01-16 |
Gw Pharma Ltd |
Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
|
|
GB2527599A
(en)
|
2014-06-27 |
2015-12-30 |
Gw Pharma Ltd |
Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy
|
|
WO2016010827A1
(en)
|
2014-07-14 |
2016-01-21 |
Librede Inc. |
Production of cannabinoids in yeast
|
|
US11293038B2
(en)
|
2014-07-14 |
2022-04-05 |
Librede Inc. |
Production of cannabinoids in yeast
|
|
BR112017003966A2
(pt)
|
2014-08-25 |
2018-10-23 |
Full Spectrum Laboratories Ltd |
aparelhos e métodos para a produção simultânea de compostos canabinoides
|
|
GB2531282A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2531278A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
GB2531281A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
MX2017005277A
(es)
|
2014-10-21 |
2018-01-11 |
United Cannabis Corp |
Extractos de cannabis y métodos de preparación y uso de la misma.
|
|
GB2539472A
(en)
|
2015-06-17 |
2016-12-21 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
US20170038184A1
(en)
|
2015-08-06 |
2017-02-09 |
Charles E. Ankner |
Formulation delivery system
|
|
US9585867B2
(en)
|
2015-08-06 |
2017-03-07 |
Charles Everett Ankner |
Cannabinod formulation for the sedation of a human or animal
|
|
GB2541191A
(en)
|
2015-08-10 |
2017-02-15 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
MX2018004632A
(es)
*
|
2015-10-16 |
2018-11-09 |
Scythian Biosciences Inc |
Metodos y composiciones para el tratamiento de una lesion cerebral traumatica.
|
|
EP3383387B1
(en)
*
|
2015-12-05 |
2025-11-05 |
Canna-B Cure Ltd |
Veterinary composition comprising cbd and/or thc for use in the treatment of stress in bees
|
|
US11172698B1
(en)
|
2016-02-08 |
2021-11-16 |
Jeff Nordahl |
Pasteurized juice formed from raw cannabis
|
|
US11191794B1
(en)
|
2016-02-08 |
2021-12-07 |
Jeff Nordahl |
Packaged hemp products formed from raw cannabis
|
|
US9956173B1
(en)
|
2016-02-08 |
2018-05-01 |
Jeff Nordahl |
Packaged frozen cubes of cannabis juice purée that are non-psychoactive
|
|
US11779622B1
(en)
|
2016-02-08 |
2023-10-10 |
Jeff Nordahl |
Packaged raw cannabis powder
|
|
PT3429580T
(pt)
*
|
2016-03-16 |
2025-08-12 |
Buzzelet Development And Technologies Ltd |
Composição de canabinoides enriquecida em terpenos
|
|
GB2548873B
(en)
|
2016-03-31 |
2020-12-02 |
Gw Res Ltd |
Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
|
|
GB2549278B
(en)
*
|
2016-04-11 |
2021-02-17 |
Gw Res Ltd |
Use of cannabidivarin in the treatment of autism spectrum disorder
|
|
GB2549277B
(en)
|
2016-04-11 |
2021-02-17 |
Gw Res Ltd |
Cannabidiolic Acid for use in the Treatment of Autism Spectrum Disorder
|
|
US10499584B2
(en)
|
2016-05-27 |
2019-12-10 |
New West Genetics |
Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
|
|
CA3010636A1
(en)
|
2016-06-29 |
2018-01-04 |
CannScience Innovations Inc. |
Decarboxylated cannabis resins, uses thereof and methods of making same
|
|
US9717683B1
(en)
|
2016-06-29 |
2017-08-01 |
Ep Pharma, Llc |
Low-temperature inhalation administration of cannabinoid entities
|
|
GB2551987A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2551986A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Parenteral formulations
|
|
GB2553139A
(en)
|
2016-08-25 |
2018-02-28 |
Gw Res Ltd |
Use of cannabinoids in the treatment of multiple myeloma
|
|
CA3077624A1
(en)
*
|
2016-10-01 |
2018-04-05 |
James Smeeding |
Pharmaceutical compositions comprising a statin and a cannabinoid and uses thereof
|
|
JP7225103B2
(ja)
*
|
2016-10-11 |
2023-02-20 |
ジービーエス グローバル バイオファーマ，インコーポレイテッド |
神経変性疾患を処置するためのカンナビノイド含有複合混合物
|
|
US10239808B1
(en)
|
2016-12-07 |
2019-03-26 |
Canopy Holdings, LLC |
Cannabis extracts
|
|
GB2557921A
(en)
|
2016-12-16 |
2018-07-04 |
Gw Res Ltd |
Use of cannabinoids in the treatment of angelman syndrome
|
|
JP7225104B2
(ja)
|
2017-02-01 |
2023-02-20 |
ジービーエス グローバル バイオファーマ，インコーポレイテッド |
マスト細胞関連炎症障害又は好塩基球媒介炎症障害の治療のためのカンナビノイド含有複合混合物
|
|
CA3053187A1
(en)
*
|
2017-02-09 |
2018-08-16 |
Bodhi Research & Development Inc. |
Cannabinoid-containing fatty acid formulations for treating disorders of the nervous system
|
|
GB2559774B
(en)
|
2017-02-17 |
2021-09-29 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2560019A
(en)
|
2017-02-27 |
2018-08-29 |
Gw Res Ltd |
Use of cannabinoids in the treatment of leukaemia
|
|
WO2018176055A2
(en)
|
2017-03-24 |
2018-09-27 |
Trait Biosciences, Inc. |
High level in vivo biosynthesis and isolation of water-soluble cannabinoids in plant systems
|
|
CN107137605A
(zh)
*
|
2017-03-27 |
2017-09-08 |
昭通天麻产业开发有限公司 |
一种由乌天麻提取物和植物大麻提取物及口服载体组成的组合物
|
|
WO2018205038A1
(en)
*
|
2017-05-12 |
2018-11-15 |
Tetra Bio-Pharma Inc. |
Compositions comprising cannabinoids and terpenes useful in the treatment of cancer and vascular ocular disorders via inhibition of hedgehog signalling
|
|
GB2564383B
(en)
|
2017-06-23 |
2021-04-21 |
Gw Res Ltd |
Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex
|
|
US11946059B2
(en)
|
2017-07-11 |
2024-04-02 |
Trait Biosciences, Inc. |
In vivo generation of water-soluble cannabinoids in plant cell suspension cultures
|
|
US11905543B2
(en)
|
2017-07-11 |
2024-02-20 |
Trait Biosceinces, Inc. |
In vivo generation of water-soluble acetylated cannabinoid glycoside compounds in plant cell suspension cultures
|
|
EP3679153A4
(en)
|
2017-07-11 |
2021-01-06 |
Trait Biosciences, Inc. |
GENERATION OF WATER-SOLUBLE CANNABINOID COMPOUNDS IN YEAST AND PLANT CELL SUSPENSION CULTURES AND COMPOSITIONS
|
|
GB2564459B
(en)
*
|
2017-07-12 |
2022-03-09 |
Gw Res Ltd |
Use of cannabinoids in the treatment of a neurodegenerative disease or disorder
|
|
US10272360B2
(en)
|
2017-08-05 |
2019-04-30 |
Priya Naturals, Inc. |
Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto
|
|
CA3076929A1
(en)
*
|
2017-09-25 |
2019-03-28 |
Canopy Health Innovations |
Compositions comprising cannabidiol, tetrahydrocannabinol, terpenes, and flavonoids and use thereof in the treatment of insomnia
|
|
US10307392B2
(en)
*
|
2017-10-21 |
2019-06-04 |
Alexander Kariman |
Compound and method for treatment of diseases and disorders
|
|
US20190183849A1
(en)
*
|
2017-10-21 |
2019-06-20 |
Alexander Kariman |
Compound and method for treatment of diseases and disorders
|
|
GB2568929A
(en)
|
2017-12-01 |
2019-06-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
US10722545B2
(en)
|
2018-01-01 |
2020-07-28 |
Alexander Kariman |
Compound and method for treatment of movement disorders
|
|
GB2569961B
(en)
|
2018-01-03 |
2021-12-22 |
Gw Res Ltd |
Pharmaceutical
|
|
US11202771B2
(en)
|
2018-01-31 |
2021-12-21 |
Treehouse Biotech, Inc. |
Hemp powder
|
|
MX2020010284A
(es)
|
2018-03-30 |
2021-02-18 |
India Globalization Capital Inc |
Método y composición para el tratamiento de los trastornos del snc.
|
|
GB201806953D0
(en)
|
2018-04-27 |
2018-06-13 |
Gw Res Ltd |
Cannabidiol Preparations
|
|
US10897925B2
(en)
|
2018-07-27 |
2021-01-26 |
Joseph Pandolfino |
Articles and formulations for smoking products and vaporizers
|
|
US20220304963A1
(en)
*
|
2018-07-27 |
2022-09-29 |
Basil Shaaban |
Composition having an optimized fatty acid excipient profile
|
|
US20200035118A1
(en)
|
2018-07-27 |
2020-01-30 |
Joseph Pandolfino |
Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
|
|
EP3864000A4
(en)
|
2018-10-10 |
2022-08-10 |
Treehouse Biosciences, Inc. |
CANNABIGEROL SYNTHESIS
|
|
AU2019375921A1
(en)
*
|
2018-11-09 |
2021-06-03 |
Agriculture Victoria Services Pty Ltd |
Plants with a cannabinoid profile enriched for cannabidiol
|
|
US20210392943A1
(en)
*
|
2018-11-09 |
2021-12-23 |
Cronos Group Inc. |
Liquid composition for an electronic vapor device
|
|
ES2986503T3
(es)
|
2019-05-03 |
2024-11-11 |
Zyus Life Sciences Inc |
Formulación para el manejo del dolor que comprende tetrahidrocannabinol (THC), cannabicromeno (CBC) y cannabidiol (CBD) en una proporción determinada
|
|
US12178797B2
(en)
|
2019-05-03 |
2024-12-31 |
Zyus Life Sciences Inc. |
Formulation for pain management
|
|
US12220396B2
(en)
|
2019-05-03 |
2025-02-11 |
Zyus Life Sciences Inc. |
Formulation for pain management
|
|
GB2584341B
(en)
|
2019-05-31 |
2023-03-01 |
Gw Res Ltd |
Cannabinoid formulations
|
|
US12557843B2
(en)
*
|
2019-07-15 |
2026-02-24 |
Raymond Louis Larson |
Other than cannabinoids, flavonoids, and terpenes
|
|
US11497249B2
(en)
|
2019-09-16 |
2022-11-15 |
Vapor Cartridge Technology Llc |
Drug delivery system with stackable substrates
|
|
US12409131B2
(en)
|
2019-10-03 |
2025-09-09 |
Pike Therapeutics Usa, Inc. |
Transdermal delivery of dronabinol
|
|
CN114650809A
(zh)
|
2019-10-03 |
2022-06-21 |
斯塔顿治疗公司 |
屈大麻酚的透皮递送
|
|
US12186280B2
(en)
|
2019-10-11 |
2025-01-07 |
Pike Therapeutics Inc. |
Pharmaceutical composition and method for treating seizure disorders
|
|
US12016829B2
(en)
|
2019-10-11 |
2024-06-25 |
Pike Therapeutics Inc. |
Pharmaceutical composition and method for treating seizure disorders
|
|
JP2022551730A
(ja)
|
2019-10-14 |
2022-12-13 |
パイク セラピューティクス，インコーポレイテッド |
カンナビジオールの経皮送達
|
|
US12268699B2
(en)
|
2019-10-14 |
2025-04-08 |
Pike Therapeutics Inc. |
Transdermal delivery of tetrahydrocannabinol
|
|
US12121617B2
(en)
|
2019-10-14 |
2024-10-22 |
Pike Therapeutics Inc. |
Transdermal delivery of cannabidiol
|
|
GB202002754D0
(en)
|
2020-02-27 |
2020-04-15 |
Gw Res Ltd |
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
|
|
US20210290564A1
(en)
*
|
2020-03-17 |
2021-09-23 |
Tauriga Sciences Inc. |
Medicated cannabinoid compositions, methods of manufacturing, and methods of treatment
|
|
CA3172253A1
(en)
|
2020-04-24 |
2021-10-28 |
Mahsa ABRISHAMI |
Cannabichromene formulation for pain management
|
|
GB202009321D0
(en)
|
2020-06-18 |
2020-08-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
US11160757B1
(en)
|
2020-10-12 |
2021-11-02 |
GW Research Limited |
pH dependent release coated microparticle cannabinoid formulations
|
|
KR20220084761A
(ko)
*
|
2020-12-14 |
2022-06-21 |
강원대학교산학협력단 |
헴프 껍질 추출물을 포함하는 인지기능 개선용 조성물
|
|
CN113368086B
(zh)
*
|
2021-08-11 |
2021-12-03 |
龙麻(上海)医药研发有限责任公司 |
一种大麻素组合物及其在制备治疗帕金森、阿尔茨海默等神经退行性疾病的药物中的应用
|
|
WO2023200906A1
(en)
|
2022-04-12 |
2023-10-19 |
Shackelford Pharma Inc. |
Treatment of seizure disorders
|
|
CA3264785A1
(en)
|
2022-08-12 |
2024-02-15 |
Jazz Pharmaceuticals Research Uk Limited |
ORAL SOLID DOSAGE FORMS CONTAINING CANNABINOIDS
|
|
AU2024206205A1
(en)
*
|
2023-01-04 |
2025-07-17 |
Florascience Inc. |
Cannabinoids for use in the treatment of a neurodegenerative disease or condition
|
|
AU2024369337A1
(en)
|
2023-10-23 |
2026-06-04 |
Inmed Pharmaceuticals Inc. |
Cannabinoids compounds and their use in the treatment of neuronal disorders
|
|
WO2025172553A1
(en)
|
2024-02-14 |
2025-08-21 |
Jazz Pharmaceuticals Research Uk Limited |
Oral solid dosage forms comprising cannabinoids
|
|
WO2025234537A1
(ko)
*
|
2024-05-07 |
2025-11-13 |
주식회사 퓨처에프바이오텍 |
대마 종자 발효물을 포함하는 비만 또는 인지기능 개선용 조성물
|
|
WO2026071793A1
(ko)
*
|
2024-09-26 |
2026-04-02 |
서울대학교산학협력단 |
대마 초임계 추출물을 포함하는 신경세포 보호용 조성물
|
|
WO2026071795A1
(ko)
*
|
2024-09-26 |
2026-04-02 |
서울대학교산학협력단 |
대마 초임계 추출물을 포함하는 근육 질환의 예방 또는 치료용 약학 조성물
|